• Regenxbio Chief Medical Officer Steve Pakola sold 2,161 shares on July 2, 2026 at USD 13.64.
• He exercised stock options for 2,161 shares at USD 7.86 on the same day.
• Pakola held 213,009 shares following the transactions.
• He held 64,812 stock options following the option exercise.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regenxbio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001700659-26-000014), on July 06, 2026, and is solely responsible for the information contained therein.